The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication

The lack of coronavirus-specific antiviral drugs has instigated multiple drug repurposing studies to redirect previously approved medicines for the treatment of SARS-CoV-2, the coronavirus behind the ongoing COVID-19 pandemic. A recent, large-scale, retrospective clinical study showed that famotidin...

Descripción completa

Detalles Bibliográficos
Autores principales: Loffredo, Madeline, Lucero, Hector, Chen, Da-Yuan, O’Connell, Aoife, Bergqvist, Simon, Munawar, Ahmad, Bandara, Asanga, De Graef, Steff, Weeks, Stephen D., Douam, Florian, Saeed, Mohsan, Munawar, Ali H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940615/
https://www.ncbi.nlm.nih.gov/pubmed/33686143
http://dx.doi.org/10.1038/s41598-021-84782-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940615/
https://www.ncbi.nlm.nih.gov/pubmed/33686143
http://dx.doi.org/10.1038/s41598-021-84782-w

Ejemplares similares